Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics
H. Lelievre et al., Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics, J CLIN MICR, 37(11), 1999, pp. 3452-3457
Oxacillin (methicillin) resistance in methicillin-resistant Staphylococcus
aureus (MRSA) is associated with an increased incidence of resistance to ot
her antibiotics, which has increased since it was first reported in 1969. I
n 1992 a new phenotype of MRSA arose in France; this nas characterized by a
heterogeneous expression of resistance to oxacillin and susceptibility to
various antibiotics, including gentamicin but also tetracycline, minocyclin
e, lincomycin, pristinamycin, co-trimoxazole, rifampin, and fusidic acid. I
n French hospitals a longitudinal nationwide surveillance of antibiotic res
istance in S. aureus has allowed for the detection of changes in antibiotic
Susceptibility profiles, Seven French clinical laboratories (six from the
mainland and one from the West Indies) reported the results of susceptibili
ty testing of 57,347 S. aureus strains isolated in their institutes between
1992 and 1998. Over a 7-year period the incidence of isolation of gentamic
in-susceptible MRSA (GS-MRSA) strains has steadily increased to represent,
in 1998, 46.8 to 94.4% of the MRSA strains, irrespective of the overall inc
idence of MRSA. Two predominant types recognized by pulsed-field gel electr
ophoresis (PFGE) accounted for the majority of the GS-MRSA in different mai
nland hospitals, both differing from the predominant type observed in the F
rench West Indies. Some GS-MRSA and gentamicin-resistant MRSA (GR-MRSA) str
ains had closely related PFGE profiles, and hybridization studies confirmed
the lack in GS-MRSA of the aac6'-apha2 " gene, which confers resistance to
all aminoglycosides, with conservation of the ant4' gene, which confers re
sistance to kanamycin, tobramycin, and amikacin. Thus, it is likely that ce
rtain GS-MRSA strains could have emerged from GR-MRSA strains by excision o
r deletion of the aac6'-apha2 " gene.